Provocation After Nurse-Directed Assessment (PANDA) Study
The University of Hong Kong
440 participants
Sep 1, 2025
OBSERVATIONAL
Summary
The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.
Eligibility
Inclusion Criteria4
- Receiving inpatient or outpatient treatment at a participating hospital during the study period;
- Possessing a documented penicillin allergy label;
- Underwent penicillin allergy evaluation by the nurse-allergist collaborative approach or the traditional allergist-led approach
- Demographic and clinical data required for the study available.
Exclusion Criteria3
- Patients unable to provide a complete medication history or history of penicillin allergy;
- Patients with only emergency or short-term treatment records;
- Patients who have taken steroids, antihistamines, or similar medications within the last 3 days.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients in this group undergo risk assessment and categorization by nurses to identify low-risk individuals for delabeling. For these patients, nurses will collaborate with allergists in the delabeling process.
Patients assigned to this group will undergo risk assessment and delabeling led by allergists for both low-risk and high-risk cases.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07127835